Cathy N Lam
Examiner (ID: 12915)
Most Active Art Unit | 2811 |
Art Unit(s) | 4122, 2811 |
Total Applications | 430 |
Issued Applications | 305 |
Pending Applications | 0 |
Abandoned Applications | 125 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9427099
[patent_doc_number] => 08703169
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-04-22
[patent_title] => 'Implantable device having a coating comprising carrageenan and a biostable polymer'
[patent_app_type] => utility
[patent_app_number] => 11/891150
[patent_app_country] => US
[patent_app_date] => 2007-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5162
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11891150
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/891150 | Implantable device having a coating comprising carrageenan and a biostable polymer | Aug 7, 2007 | Issued |
Array
(
[id] => 4689356
[patent_doc_number] => 20080033537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'BIODEGRADABLE STENT HAVING AN ACTIVE COATING'
[patent_app_type] => utility
[patent_app_number] => 11/834432
[patent_app_country] => US
[patent_app_date] => 2007-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3032
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20080033537.pdf
[firstpage_image] =>[orig_patent_app_number] => 11834432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/834432 | BIODEGRADABLE STENT HAVING AN ACTIVE COATING | Aug 5, 2007 | Abandoned |
Array
(
[id] => 5465792
[patent_doc_number] => 20090325992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/375841
[patent_app_country] => US
[patent_app_date] => 2007-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79371
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375841 | COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF | Jul 29, 2007 | Abandoned |
Array
(
[id] => 6598439
[patent_doc_number] => 20100048707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Polymeric Reagents Comprising a Terminal Vinylic Group and Conjugates Formed Therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/374297
[patent_app_country] => US
[patent_app_date] => 2007-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 31201
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048707.pdf
[firstpage_image] =>[orig_patent_app_number] => 12374297
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374297 | Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom | Jul 19, 2007 | Issued |
Array
(
[id] => 6495697
[patent_doc_number] => 20100010025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Pyrimidine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/374524
[patent_app_country] => US
[patent_app_date] => 2007-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9681
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12374524
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374524 | Pyrimidine Derivatives | Jul 18, 2007 | Abandoned |
Array
(
[id] => 5290059
[patent_doc_number] => 20090022789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'ENHANCED FORMULATIONS OF LAMOTRIGINE'
[patent_app_type] => utility
[patent_app_number] => 11/779562
[patent_app_country] => US
[patent_app_date] => 2007-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3320
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022789.pdf
[firstpage_image] =>[orig_patent_app_number] => 11779562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/779562 | ENHANCED FORMULATIONS OF LAMOTRIGINE | Jul 17, 2007 | Abandoned |
Array
(
[id] => 10049772
[patent_doc_number] => 09089627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Stent fabricated from polymer composite toughened by a dispersed phase'
[patent_app_type] => utility
[patent_app_number] => 11/827180
[patent_app_country] => US
[patent_app_date] => 2007-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 6126
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11827180
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/827180 | Stent fabricated from polymer composite toughened by a dispersed phase | Jul 9, 2007 | Issued |
Array
(
[id] => 5374725
[patent_doc_number] => 20090312286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'DERIVATIVES OF 4-TRIMETHYLAMMONIUM-3-AMINOBUTYRATE AND 4-TRIMETHYLPHOSPHONIUM-3-AMINOBUTYRATE AS CPT-INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/374774
[patent_app_country] => US
[patent_app_date] => 2007-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7224
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312286.pdf
[firstpage_image] =>[orig_patent_app_number] => 12374774
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374774 | DERIVATIVES OF 4-TRIMETHYLAMMONIUM-3-AMINOBUTYRATE AND 4-TRIMETHYLPHOSPHONIUM-3-AMINOBUTYRATE AS CPT-INHIBITORS | Jul 9, 2007 | Abandoned |
Array
(
[id] => 6307126
[patent_doc_number] => 20100069392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Combination of HMG-COA Reductase Inhibitors with Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Pulmonary Disease'
[patent_app_type] => utility
[patent_app_number] => 12/308878
[patent_app_country] => US
[patent_app_date] => 2007-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6915
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069392.pdf
[firstpage_image] =>[orig_patent_app_number] => 12308878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/308878 | Combination of HMG-COA Reductase Inhibitors with Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Pulmonary Disease | Jul 2, 2007 | Abandoned |
Array
(
[id] => 4751902
[patent_doc_number] => 20080159975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Hair treatment composition, hair treatment agent and method for treating hair by using the same'
[patent_app_type] => utility
[patent_app_number] => 11/824400
[patent_app_country] => US
[patent_app_date] => 2007-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9216
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20080159975.pdf
[firstpage_image] =>[orig_patent_app_number] => 11824400
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/824400 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Jun 27, 2007 | Abandoned |
Array
(
[id] => 10096894
[patent_doc_number] => 09133195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/305174
[patent_app_country] => US
[patent_app_date] => 2007-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 11441
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12305174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305174 | Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof | Jun 14, 2007 | Issued |
Array
(
[id] => 6320136
[patent_doc_number] => 20100196290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'COMPOSITIONS COMPRISING BETULONIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/303665
[patent_app_country] => US
[patent_app_date] => 2007-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25181
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196290.pdf
[firstpage_image] =>[orig_patent_app_number] => 12303665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/303665 | COMPOSITIONS COMPRISING BETULONIC ACID | Jun 5, 2007 | Abandoned |
Array
(
[id] => 4710650
[patent_doc_number] => 20080299176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'DRUG DELIVERY DEVICE COMPRISING CROSSLINKED POLYURETHANE-SILOXANE-CONTAINING COPOLYMERS'
[patent_app_type] => utility
[patent_app_number] => 11/755211
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4268
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299176.pdf
[firstpage_image] =>[orig_patent_app_number] => 11755211
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/755211 | DRUG DELIVERY DEVICE COMPRISING CROSSLINKED POLYURETHANE-SILOXANE-CONTAINING COPOLYMERS | May 29, 2007 | Abandoned |
Array
(
[id] => 9440986
[patent_doc_number] => 08710097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Flavonoid dimers and methods of making and using such'
[patent_app_type] => utility
[patent_app_number] => 12/301504
[patent_app_country] => US
[patent_app_date] => 2007-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 44
[patent_no_of_words] => 26399
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12301504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/301504 | Flavonoid dimers and methods of making and using such | May 8, 2007 | Issued |
Array
(
[id] => 8653241
[patent_doc_number] => 08372990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Bicyclic tetrahydropyrrole compounds'
[patent_app_type] => utility
[patent_app_number] => 12/226559
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27728
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12226559
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226559 | Bicyclic tetrahydropyrrole compounds | Apr 29, 2007 | Issued |
Array
(
[id] => 5474306
[patent_doc_number] => 20090247472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/298307
[patent_app_country] => US
[patent_app_date] => 2007-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22535
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298307 | TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS | Apr 24, 2007 | Abandoned |
Array
(
[id] => 10888176
[patent_doc_number] => 08912172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Skin external preparation containing triterpenic acid'
[patent_app_type] => utility
[patent_app_number] => 12/305350
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5552
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12305350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305350 | Skin external preparation containing triterpenic acid | Apr 23, 2007 | Issued |
Array
(
[id] => 8725609
[patent_doc_number] => 08404726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Activating agent for peroxisome proliferator activated receptor δ'
[patent_app_type] => utility
[patent_app_number] => 12/297436
[patent_app_country] => US
[patent_app_date] => 2007-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18788
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12297436
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297436 | Activating agent for peroxisome proliferator activated receptor δ | Apr 17, 2007 | Issued |
Array
(
[id] => 4664751
[patent_doc_number] => 20080255658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Degradation Associated Drug Delivery for Drug Eluting Stent and Medical Device Coatings'
[patent_app_type] => utility
[patent_app_number] => 11/734388
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3295
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11734388
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/734388 | Degradation Associated Drug Delivery for Drug Eluting Stent and Medical Device Coatings | Apr 11, 2007 | Abandoned |
Array
(
[id] => 5391257
[patent_doc_number] => 20090208570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Extended Release Dosage forms of Metoprolol'
[patent_app_type] => utility
[patent_app_number] => 12/225746
[patent_app_country] => US
[patent_app_date] => 2007-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3740
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225746
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225746 | Extended release dosage forms of metoprolol | Mar 27, 2007 | Issued |